Side-by-side comparison of AI visibility scores, market position, and capabilities
Plymouth MN phosphate and potash fertilizer (NYSE: MOS) ~$11.2B FY2024 revenue; largest US phosphate producer, Saskatchewan potash, Brazil distribution, post-2022 price normalization competing with Nutrien and OCP.
The Mosaic Company is a Plymouth, Minnesota-based fertilizer company — publicly traded on the New York Stock Exchange (NYSE: MOS) as an S&P 500 Materials component — producing and selling potash (potassium-based fertilizer mined from underground ore deposits) and phosphate (phosphate rock mining and processing into diammonium phosphate, monoammonium phosphate, and triple superphosphate fertilizers) critical for global agricultural production through approximately 13,000 employees. Mosaic is the largest US producer of concentrated phosphate and potash and one of the largest producers globally, with phosphate mining operations in Florida and North Carolina (mines at Wingate Creek, South Fort Meade, and Four Corners) and Canada (Saskatchewan potash mines at Esterhazy, Belle Plaine, and Colonsay), and operations in Brazil (mining and blending), Australia, and internationally. In fiscal year 2024, Mosaic reported revenues of approximately $11.2 billion and adjusted EBITDA of approximately $2.5 billion, navigating potash price normalization from the extraordinary 2022 spike ($1,000/metric ton potash following Russia and Belarus sanctions that disrupted 40% of global potash supply — driving prices up 4x from 2021 baseline) down to $200-250/MT range by late 2024 as Belarusian potash found alternative export routes through Russia and Chinese ports. CEO Bruce Bodine, appointed in 2023 after Joc O'Rourke's retirement, focuses Mosaic's strategy on operational efficiency and Brazilian market expansion as price normalization compresses margins versus the 2022 supercycle that generated exceptional profitability.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.